While its current pricing requires up-to-date information beyond the scope of its notable pricing events, Daraprim was indeed priced at $750 per pill in early 2016.
Daraprim's Price in 2016
In February 2016, when its price was a subject of widespread public and congressional scrutiny, Daraprim maintained a consistent price of $750 per pill. This cost had been in effect for approximately four months prior to that time, marking a significant increase from its previous price of $13.50.
Context of the $750 Price
The drug, which treats toxoplasmosis, an infection that can be life-threatening for individuals with weakened immune systems, gained notoriety after its acquisition by Turing Pharmaceuticals (later Vyera Pharmaceuticals). The dramatic price hike led to significant controversy and public outcry. Despite the intense public debate and a scheduled testimony before the House Committee on Oversight and Government Reform, the price remained fixed at $750 per pill.
